Infectious Flashcards
improvements cap 1 wk- 4wks-6wks-3mos-6mospoppy
1 week - FEVER should have resolved
4 weeks - CHEST PAIN and SPUTUM PRODUCTION should have substantially reduced
6 weeks - COUGH and BREATHLESSNESS should have substantially reduced
3 months - most SYMPTOMS should have resolved BUT FATIGUE may still be present
6 months - most people will feel back to NORMAL
repeat cxr cap when?
4-6wks
ptb tx for cat 1new? cat 1a-bone joint meninge? cat 2retreatment? cat 2a retreatment?
Category 1 - New Cases of all forms of TB (except Meninges, Bone, and Joints): 2HRZE/4HR - 6 months total
Category 1a - New Cases TB of the Meninges, Bone, and Joints): 2HRZE/10HR - 12 months total
Category 2 - Retreatment cases of all forms of TB (except Meninges, Bone, and Joints): 2HRZES/1HRZE/5HRE - 8 months total
Category 2a - Retreatment cases of of TB of Meninges, Bone, and Joints): 2HRZES/1HRZE/9HRE - 12 months total
- TB 2016, CPG, p94 -
tb tx regimen: renal? dm? pregnant? compensated cirrhosis? decompensated cirrhosis? sot low risk? sot high risk?
> What is the recommended treatment regimen for patients with CKD?
ANSWER: Same with the general population but with dose adjustment of Ethambutol and Pyrazinamide depending on the EGFR. For HD patients, give HRZE post HD.
DM - same with general population
Pregant - same with general population
Compensated Liver Cirrhosis - DO NOT GIVE PYRAZINAMIDE: 2HRSE/6HR or 2HSE/10HE or 9HRE
Decompensated Liver Cirrhosis: Refer to specialized center for 2nd Line Drugs
Post-SOT recipients without risk factor of drug resistance (mild, non-cavitary, non-miliary, not-extra-pulmonary, and clinically diagnosed): 2HEZ/12-18HE, avoid RIFAMPICIN due to interaction with immunosuppresive drugs
Post-SOT recipients, severe cases (disseminated, cavitary, bacteriologically positive): 2HRZE/4-9HR… Just monitor the drug level of the immunosuppresive drugs
- TB 2016, CPG, pp152-163 -
1st line tx uncomplicated uti
nictrofurantoin monohydrate/macrocrystals 100mg bid x 7 days; fosfomycin 3g single dose
treatment cryptococcal meningitis
- Induction: Ampho B (0.7-1.0 mg/kg) + Fluco 800 PO/IV ODx 2 weeks or until cultures are negative
- Consilidation: Fluco 400 PO/IV OD for at least 8 weeks
- Maintenance: Fluco 200 PO OD for at least 1 year until there is reconstitution of symptoms- Fungal Culture after 2 weeks to ensure clearance - CALAS and CSF India Ink SHOULD NOT BE USED to monitor response to treatment
- Monitor Ampho B’s dose dependent nephrotoxicity and electrolyte imbalance
- Monitor Fluco’s hepatotoxicity
urine ph indication for imaging in uti
7.0
duration of retreatment for uti with recurrence
- 2 weeks: absence of urologic abnormality
- 4-6 weeks: symptoms recus and whose Urine CS shows the same organism as the initial infecting organism
complicated uti definition
- Functional or anatomic ABNORMALITY of urinary tract or kidneys
OR
- Underlying disease that INTERFERES with host defense mechanisms
OR
- Condition that increases the RISK of persistent infection and/or treatment failure
significant bacteruria
complicated uti >100, 000 cfu clean catch urine;
What is the treatment regimen of choice for Toxoplasmosis Encephalitis in HIV?
ANSWER: S-P-F ( Sulfadiazine, Pyrimethamine, and Folinic Acid or Leucovorin)
Duration of treatment
CAP
In general
Low risk: 5-7 days
Moderate risk: 7-10 days
Duration of treatment
CAP
MSSA Comunity acquired
Non bacteremic - 7-14 days
Bacteremic - upto 21 days
Duration of treatment
CAP
MRSA Community acquired
Nonbacteremic - 7-21 days
Bacteremic - upto 28 days
Duration of treatment
CAP
Pseudomonas
Nonbacteremic - 14 - 21 days
Bacteremic - upto 28 days
Duration of treatment
CAP
Legionella
14- 21 days
10 days (azalides)